Immunoregulation in Atopic Dermatitis: Functional Analysis of T-B Cell Interactions and the Enumeration of Fc Receptor-Bearing T Cells  by Cooper, Kevin D. et al.
0022-202X/ 83/ 8003-0139$02.00/ 0 
THE JOURNAL OF lNVES'I'I GATIVE DERMATOLOGY, 80:139-145, 1983 
Copyright © 1983 by The Williams & Wilkins Co. 
Vol. 80, No. 3 
Printed in U.S.A. 
REPORTS 
Immunoregulation in Atopic Dermatitis: Functional Analysis ofT-B Cell 
Interactions and the Enumeration of Fe Receptor-Bearing T Cells* 
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JoN M. HANIFIN, M.D. 
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Immune aberrations in atopic dermatitis (AD) are mul-
tiple and interrelated. We investigated immunoregula-
tory cell markers and functional interactions of purified 
T- and B-enriched cells in a pokeweed mitogen (PWM)-
stimulated IgG production assay in patients with AD. 
Atopic mononuclear leukocytes and autologous recom-
binations of purified atopic T and B cells were hypores-
ponsive to PWM stimulation of lgG synthesis. When 
atopic B cells were cultured with normal T cells, they 
were still less responsive than normal B cells. Atopic T 
cells generated normal levels of suppression in three 
responder systems. Radioresistant T-cell help was also 
in the normal range whereas noriirradiated AD T cells 
produced slightly less help than normal T cells. We noted 
reduced levels of T lymphocytes with FclgG receptors 
(Ty) and found that Ty reduction correlated inversely 
with log serum IgE. In the light of normal T suppression, 
we critically examined AD cell adherence and contami-
nation at various steps in the Ty assay to rule out tech-
nical causes of Ty reduction in AD. Lowered Ty cells in 
AD were not associated with circulating lgG immune 
complexes and subsequent blockade of the FclgG recep-
tors. 
Thus, we have identified defects in the numbers of an 
immunoregulatory T cell, and in the generation ofPWM-
responsive B cells. A model is proposed in which the 
alterations in atopic cyclic nucleotide metabolism ofT-
cell helpers could result in abnormalities of immunoreg-
ulatory T cells and PWM-recruitable B cells. 
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Abbrevia tions: 
AD: atopic dermatitis 
ADCC: antibody-dependent cellular cytotoxir;ity 
ANAE: acid a-napthyl acetate esterase 
BSS: balanced salt solu tion 
E: erytlu-ocyte(s) 
ERFC: E rosette-forming cells 
FBS: fetal bovine serum 
MGG: May Grunwald-Geimsa (stain) 
MLR: mixed lymphocyte reaction 
MNL: mononuclear leukocyte(s) 
N: normal controls 
NK: natural killer cell(s) 
OE: ox erythrocyte(s) 
PBL: peripheral blood lymphocytes 
PWM: pokeweed mitogen 
RFC: rosette-forming cells 
Slg: immunoglobulin-bearing cells 
SLE: systemic lupus erythmatosus 
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Immunologic abnormalities associated with atopic dermatitis 
(AD) include decreased circulating Ty cells (T lymphocytes 
with FclgG receptors) [1], elevated serum IgE [2], defective 
antibody-dependent cellular cytotoxicity (ADCC) [3,4], de-
pressed lymphocyte responses to mitogens [5], and depressed 
granulocyte and monocyte chemotaxis [6]. In the skin there is 
often cutaneous anergy [7], increased susceptibility to cuta-
neous viral and fungal infections, and a spongiotic dermatitis 
with a T-cell perivascular infiltrate [8]. 
Several studies on spontaneous IgE production by terminally 
differentiated B cells have revealed a lack of T-suppressor 
activity by cells from some AD patients [9,10]. However, these 
findings have not been consistent and some patients whose 
mononuclear leukocytes (MNL) overproduce IgE clearly have 
normal T-suppressor function [9,10]. These inconsistencies sug-
gested a more complex situation than previously appreciated 
and prompted us to explore multiple basic aspects ofT- and B-
cell function as well as to examine more critically the factors 
contributing toT-cell reduction in AD. 
We employed a pokeweed mitogen (PWM)-stimulated IgG 
production assay to explore independently such variables as T-
suppressor function , radiosensitive T -helper function, B-cell 
fun ction, and T-B cell interactions [11-15]. The PWM system 
assays more directly for the Ty suppressor of lgG synthesis in 
that the PWM-activated suppressor derives predominantly 
from the Ty cell (13,15], whereas the Con-A activated suppres-
sor derives from both Ty and TJ.L cells [16] as well as from 
monoclonal antibody OKTa+ cells [18]. In this system, Ty cells 
(T cells with FclgG receptors) [15,17] and monoclonal antibody-
defined OKT8+ cells [18] provide radiosensitive suppression of 
B-cell function (through inhibition of T-cell help) [18, 
19]. Although previously controversial, Ty cells do indeed ap-
pear to be of T-cell lineage since they express most T-cell 
antigens [20]. TJ.L cells (T cells with Fe receptors for lgM) [17] 
and OKT1 + cells [18] pwvide help for PWM-stimulated B cell 
lg production. Both radioresistant and radiosensitive T -cell 
help [19-24] is involved in PWM recruitment of recent memory 
B cells into IgG-producing cells [25]. 
In this report we observed decreased in vitro IgG production, 
reflecting a reduction in PWM-recruitable B cells. We noted 
decreased Ty cells and an elevated TJ.L/ Ty ratio. Despite the 
abnormal TJ.L/ Ty ratio and hyporesponsive PWM-stimulated 
immunoglobulin production, AD T cells suppressed normally 
in three responder systems and provided normal levels of radi-
oresistant help for PWM-stimulated immunoglobulin synthesis 
in vitro. A model to explain the observed abnormalities is 
proposed. 
MATERIALS AND METHODS 
Subjects 
Patients with AD showed the previously described criteria fo r diag-
nosis [7). Disease activity was graded on a scale of l-5 [6] and all were 
at least Grade 3 for both extent and severity. Topical and systemic 
medications were withheld for at least 48 h prior to the study, and 
many patients had received no therapy prior to testing. None of the 
140 COOPER ET AL 
patients had received systemic corticosteroids within the prior 2 weeks. 
Average patient age was 28.3 (range, 11-40); 62% were female and 38% 
were male. Control subjects were normal, healthy, nonatopic young 
adul ts, mean age 27.4 (range, 23-33); 53% were female and 47% were 
male. All experiments could no t be performed on each subject due to 
limi tations of ce ll yield . 
Preparation of Antibody-Coated Ox Erythrocytes 
Rabbits were ini tia lly immunized in tramusculru·ly in foot pads with 
ox erythi'Ocytes (OE) in Freund's complete adjuva nt. lgM-rich antise-
rum was prepru·ed over a n ACA-34 Ult rogel column (LKB, Bromma, 
Sweden) and lgG-rich antiserum was pUl'ified over a protein A-Seph-
arose CL-4B column (Phru·macia, Piscataway, New J ersey). The purity 
of the fractions was confirmed by immunodiffus ion and the plateau 
dilu tions for optima l rosette formation with T cells were determined. 
The lgG fraction was stored at 1:2 dilution, hemolytic Liter 1:32, protein 
concentration 1.6 mg/ml. The lgM fraction was s tored at 1:2 dilution, 
hemolytic titer 1:256, protein concentration 0.8 mg/ml. 
For use, a frozen a liquot of the rabbit anti-OE was thawed fresh daily 
and an equal volume of 5% OE in balanced salt solu tion (BSS) was 
added, foll owed by incubation at 37°C for 30 min. The sensitized cells 
were washed 3 t imes and resuspended a t a 1% suspension (OEA-IgG 
or OEA-IgM) for subsequent T y and TIL de terminat ions. 
CelL Separation 
Heparinized blood (0.1 ml/lO ml) was drawn from a n atopic donor 
and at least one control donor, and MNL were purified by Ficoll-
Hypaque cent rifugation [26). Monocytes were removed by adherence 
to plastic flasks in 15% feta l bovine serum (FBS). Nonadherent periph-
eral blood lymphocytes (PBL) were then mixed with a n equa l volume 
of I% neuram inidase-treated sheep erythrocytes (E) in the presence of 
20% FBS [17]. The mixture was incubated at 37°C fo r 15 min, spun 
gently at 200 g for 5 min and incubated J h at 4°C. 
The pellet was gently resuspended, an a liquot removed for percent 
E rosette-forming ce lls (ERFC), and the remainder layered on cold 
Fico ll -Hypaque and centrifuged at 400 g for 30 min at 4 °C. The 
interface (T cell -depleted or B-enriched cell fraction) a nd pellet frac-
t ions were harvested separa te ly and the rosetted ce lls in the pell et 
passed through Fico ll -Hypaque again for greater purity (> 90% ERFC 
in pellet). ERFC in the pellet were lysed wi th cold NH.Cl buffer (T-cell 
fract ion). 
The T-cell fractio n consisted nf > 90% ERFC, 3.2 ± 1.6% surface 
immunvglobulin-bearing (Sig) cells, 2.19 ± 0.9% phagocytic monocytes, 
and 0.97 ± 0.1% acid <r- napthyl esterase (ANAE) [27) positive mono-
cytes. The B-enriched fraction consisted of 12.9 ± 5.9% ERFC, 26 ± 
10% Slg ce lls, and 27 ± 10.3% monocytes by phagocytosis or 34 ± 6.8% 
monocytes by esterase. 
T -ce ll subpopulations were separated by rose tting purified T cells at 
4 X 10"/ml in BSS with an equal volume of 1% OEA-IgG and centrif-
ugation at 200 g for 5 min, incubation at 4 °C for 1 h, and subsequent 
passage through Ficoll -Hypaque. Interface cells (Tnony cells) were 
harvested and washed and the rosetted pe ll et aga in passed through 
Fico ll -Hypaque. OE in the pe llet were lysed with NH.,Cl and the 
resultant lymphocytes washed (Ty cells). 
T-Cell Subsets 
Triplicate a liquots of 100 Ill of washed T cells at 4 x lO" per ml in 
BSS were mixed with 100 Ill of OEA-lgG or OEA-lgM, pe lleted at 200 
g for 5 min, and incubated at 4°C for 1 h. The pellet was gently 
resuspended, 3 ctrops or 0.1% to luidine blue in PBS added, and the 
percent rosette-forming ce lls (RFC) counted in a hemocytometer. The 
specimens were blinded as to normal or atopic origin and coun ted by 
the same observer throughout the study. For TIL enumeration, T ce lls 
were cul tured for 40 h prior to Fc-lgM receptor detection since incu-
bation of the T ce lls in FBS-containing media was necessary to express 
Fc-IgM receptors and the number of TIL ce lls plateaus at 40 h [28). 
Cytocentrifuged, fresh ly purified T cells were immediately stained wi th 
May Grunwald-Geimsa (MGG), which stains predominantly T y cells, 
or for ANAE activity, which stains predominantly TIL cells, as described 
by Grossi et a l [29l 
IgG Assay 
Three hundred microliters of cocu lturc su,)ernatant was reacted with 
I ml of rabbit antihuman lgG coupled to polyacrylamide beads (lm-
munobeads, BioRad Labs, Richmond, Ca lifornia) . Fluorescent ra bbit 
antihuman lgG (BioRad) was reacted with the beads, unreacted anti-
body washed out by repeated centrifugation, and the relative flu01·es-
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cence determined on an Aminco-Bowman spectrophotoflu orometer 
(American Inst .. Co., Si lver Spring, Maryland) at 485 nm excitation and 
525 nm emission. An lgG standa rd curve was determined for each 
assay. The coefficient of varia tion was< 10%. Resul ts were expressed 
as ng per ml. 
lgG Synthesis Cultures 
Responder ce lls consisted of eith er a llogeneic (for both the norma l 
and atopic T-ce ll preparations), MNL, or B-enriched cells at 1 x 10° 
ce lls per ml from the norma l and atopic subj ects. Purified T cells from 
the normal and atopic donors were added in equal volumes at vru·ying 
concentrations ranging from 0 to 5 X 10" T ce lls per ml RPMI-15% 
FBS. Cultures were stimulated with PWM (1: 100 fina l concentration 
in 1 ml tota l volume) (GIBCO) a nd placed in cul ture for 7 days, at 
which time the cocul tu res were vortexed, spun at 750 g X 10 min, and 
the supernatants were co llected for IgG determination. P ercent sup-
pression was calculated fJ'Om the formula 
(suppressor or test cocultW'e) 
%S = 1- X 100 (optima l helper coculture) 
which refl ects the ratio of observed/expected lgG synthesis. The opti-
mal helper cocul ture was the culture with a helper concentra tion ofT 
ce lls (0.1 or 1.0 X 10"/ ml) that gave the optimal response. This repre-
sented the reference control va lue from which % of optima l help and 
%suppression were calculated. Percent of optima l help for lgG synthe-
s is was calculated from the formula 
(test coculture) 
%H = X 100 (optimal helper coculture) · 
Cul tures were performed in duplicate or trip licate. 
Radioresistant Helper- Cell Cocultures 
Prior to mixing with responder ce lls, T ce lls were irradiated with 
2000 r from a ""cesium i"rradia tor to remove suppressor cell influences 
[11-14,30]. Resul ts were expressed as percent increase of lgG synthe-
s ized over the control nonirradiated cocultures. 
Raji Cell A.~say for l gG Immune Complexes 
Levels of lgG immune complexes were determined as previously 
described [31l Briefl y, 25 Ill of test sera at a I :2 d ilu tion was added to 
25 Il l of Raji ce lls at 2 x lOn/ml, incubated for 45 min at 37°C, a nd 
reacted with 11"1-la beled anti human lgG. Resul ts were expres:;ed as 
coun ts/ min '"'' I-labe led a ntihuman lgG bound to the Raj i cells . 
Serum IgE Assay 
lgE was de termined by the PRIST method (Pha rmacia). 
RESULTS 
In Vitro IgG Synthesis by Normal Cells 
B-enriched cells were cultured for 7 d ays in the presence of 
PWM, with or without a dde d T cells at varying concentrations 
(Fig 1, B + T). N egligible lgG syn t hesis o ccurred if no T cells 
we re presen t (460 ± 160 ng/ ml). The requiremen t for T-cell 
h e lp was evid e nt at low T :B r atios under 1:1 with optimal lgG 
synthesis observed with 0.1 X 10'; T cells whe n cocul t ured with 
1 X 10n B cells . Addition ofT cells at ratios of 1:1 or greater 
resul ted in dose-depende nt suppression of optimallgG synthe-
s is from th e m ean maximal level of 2038 ± 390 n g/ml down to 
564 ± 125 ng/ml. 
Irra diation of th e T cells with 2000 r prior to coculture 
reduced t h e s uppressive effect of t h e T cells, as r efle c te d by n et 
high er l gG synthesis at both the 1:1 (2995 ± 480 ng/ ml, n = 9) 
and 5:1 (1 255 ± 340 ng/ml, n = 7) ratios (Fig I , B + Irr-T). 
These results d e mons trate the presence of radiosens itive s up-
presso r cells and radioresistant h e lper cells in th is system [19]-
Addition of e ve n s mall quantities ofT cells to MNL (whic h 
a lready con tained a pproximate ly 70% T cells) resulted in s up-
pression (Fig l , MNL + T) s ince T :B ratios were approximately 
3:1, 5: 1, and 19:1, r espective ly, for the 0.1, 1.0, and 5 X 10';/mi 
concentrations. The overall lowe r net IgG synthesis may r efl ect 
lower proportions of B cells . 
That s uppressio n in t his system is mediated predominantly 
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FIG l. EffecL of added norma l T ce lls on IgG product ion by P WM-
stimulated autologous normal B-enriched ce lls (e e) or a lloge-
neic normal MNL (0 - - - 0 ) at 1 X 10'; per mi. The effect of irradiation 
of T cells prior to addi tion to B cells is shown (.4---.4) Panel B 
demonstrates the effect of T y-depleted (T nony ce lls) and enriched (Ty) 
ce lls on IgG production by auto logous MNL. 
by T y is demonstrated in Fig 1 (panel B) , where T y-cell deple-
tion (Tnony cells) resul ted in no suppression of opt imal IgG 
synt hesis by MNL whereas T y enrichment resul ted in suppres-
s ion of l gG production . 
Comparison of IgG Production by Normal and Atopic Cells 
Unfi·actionated MNL were cul tm ed in the presence of P WM 
for 1 week, then assayed for l gG (Fig 2, panel A) . To apply 
parametric tests, the data were tra nsformed to a normal distri-
bu t ion using logarithms. Mean log l gG produced by AD cells 
(5.6 ± 0.4) was significantly less than by normal cells (6.6 ± 
0.2), p < 0.05 by Students t- test for paired data. Nonparametric 
a na lysis confirmed the significa nt differences between median 
l gG production by AD pati ents (230 ng, n = 11) , compared to 
controls (812 ng, n = 15) (p < 0.05 by Wilcoxon rank sum test) . 
In Fig 2 (pa nel B) , recombinations of pmified B-emich ed cells 
a nd autologous T cells from the same donor a t helper ratios of 
< 1:1 were used . Logari t hmic conversion to a normal distribu-
t ion demonstrated the lower lgG production by AD cells (6.9 
± 0.22) vs. normal cells (7.45 ± 0.18, p < 0.01 by t-test for pa i1·ed 
data) . Again , nonparametric a nalysis confirmed lower median 
IgG production in AD cultures (1092 ng) vs. normal cul tures 
(1778 ng) (n = 17 pau·s), (p < 0.01 by Wilcoxon rank sum) . 
T o explore whether this was a T- or B-ceH defect, AD Band 
normal B-enriched cells were compared in their abili ty to 
produ ce lgG when cocul tured with normal T cells. In t he 
absence ofT-cell help (Fig 3) (i .e., wi th no T cells added) , less 
t han optimal IgG synthesis occuned. In the presence of added 
T cells, atopic B cells produced significantly less l gG than 
normal B cells. With 1 X 106/ ml normal T cells added, normal 
B cells produced 89 ± 4.3%, of opt imal IgG synthesis while 
atopic B cells produced 58 ± 9.4% (n = 10) ( p < 0.01 by t- test) 
(Fig 3). With 0.1 X 10';/ml normal T cells added, normal B cells 
produced 89 ± 5%, of optimal IgG synt hesis vs. 62 ± 10% 
produced by the atopic cells (n = 9) (p < 0.05 by t-test). When 
cultured with atopic T cells at 1.0 X 10~;/ml , AD B-enriched 
cells still produced less IgG than normal, AD-B = 57 ± 5.3% as 
compared to N-B = 73 ± 8.4%, n = 10, p < 0.05 for paired t-test. 
The reduction was not du e to fewer B cells or to increased 
numbers of suppressive monocytes in AD since we found no 
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FIG 3. Comparison of atopic dermatitis (A D ) and normal (N) B-
enriched cells (1 x 10';/ ml ) lgG synthesis when cul tured with varying 
concentra tions of normal T cells. 
statistical differences between normal (37 ± 2.4% Sl g+ cells, 10 
± 1.4% monocytes) and AD (49 ± 6.7% Si g+ cells, 11.5 ± 0.5% 
monocytes) in "B-enriched" cell populations, n = 5, p > 0.05. 
Functional analysis of monocyte suppression was not evaluated. 
Assays ofT- Suppressor Function 
We compared normal and atopic T-cell suppression ofPWM-
stimulated lgG synthesis in cultures of normal MNL from a 
third normal donor. Normal MNL without added T cells were 
used to give the opt imal or refer ence 100% response. Allogeneic 
cells were used to obviate any possible selective a llogeneic 
effect. Normal and AD T cells suppressed similarly at all 3 
concentrations tested (Table I , MNL) . 
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TABLE I. Comparison of suppressive effect of added Nor A D T cells 
on responder lgG production, as % suppression 
Responder: MNL" 
Concentration ofT cells added 
N-T 
AD-T 
n = 6 pairs 
0.1 
8.9 ± 14 
21 ± 4.8 
p > 0.05 
1.0 
63.2 ± 3.9 
58.1 ± 10.1 
p > 0.05 
5.0 
96.5 ± 2.3 
85.4 ± 9 .0 
p > 0.05 
Responder: B-enriched cells 
AD-B N-B 
N-T" 75.3 ± 5.2 
AD-T 72.6 ± 5.7 
n = 10 pau·s p > 0.05 
"Responder cells at 1 x 106 / mi. 
"T cells 5 X 106/ml. 
64.2 ± 8.84 
71.7 ± 6.32 
p > 0.05 
To further dissect the system, normal a nd atopic T cells at 
the suppressive 5 X 106 / ml concentration were added to normal 
and AD B-enriched cells and PWM (Table I , B-enriched re-
sponders). In these experiments, the combination of normal B 
and normal T cells, and the combination of atopic B and atopic 
T cells, were autologous mixtures. Results were expressed as 
% suppression of the optimal response by the B-cell population 
being tested (i.e., % suppression of optimal normal B-cell pro-
duction or % suppression of atopic B-cell production). 
T here were no statistical differences in suppression between 
normal and AD T cells. Thus, in all 3 responder systems 
analyzed (allogeneic MNL, normal B-enriched, and AD B -en-
riched), atopic T cells genemted a normal net suppression of 
PWM-induced IgG production. 
A concern in using cocultures of non-HLA matched individ-
uals was the possible effect of an allogeneic mixed lymphocyte 
reaction (MLR) on detection of suppression. Evidence against 
MLR mediation of suppression by high ratios of T cells was 
provided by the similar suppression in autologous (Fig 1) and 
allogeneic (Table I , Fig 3) systems. If only autologous suppres-
sive combinations were examined, there was still no significant 
difference between normal and AD T cell suppression, 64.2 ± 
8.8% suppression in normal cultures vs. 72.6 ± 5.7% (AD), n = 
10, p > 0.05 (Table I, B-enriched cells). 
Assays ofT-Helper Function 
Assessment ofT-helper function was accomplished by abro-
gating suppressor cell influences with T-cell irradiation (2000 r) 
prior to coculture. Since T suppressors for PWM stimulation 
are sensit ive to this dose [11-14], radioresistant helper activity 
was assayed with minimal interference from suppressor cells. 
lnadiated T cells were added in a 1:1 ratio to noniJ:radiated 
normal responder B cells. Cocultures with irradiated AD T cells 
(allogeneic) produced an increase of 72 ± 16% over control 
nonirradiated cocultures at the same T-cell concentration, 
whereas irradiated normal T-cell cocultures (autologous) pro-
duced a 125 ± 46% increase (n = 8 pairs, p > 0.05 by t-test or 
Wilcoxon rank sum) . With 5 X 106/ml T cells added, again, no 
significant differences. were found. Thus, at both concentrations 
of i:rradiated T cells tested, there were no significant differences 
between normal and AD radioresistant help. 
Radiosensitive help was unable to be tested directly without 
the presence of radioresistant T -cell help. However, when non-
irradiated T cells (at the 0.1 . X 106 / ml helper concentration) 
were cul tured with normal B cells, AD T cells provided 60 ± 
13% of optimal help as compared to 89 ± 5% with normal T 
cells (p < 0.05) (Table II). At the 1.0 X' 106 / ml helper concen-
tration the difference was less dramatic (0.1 > p > 0.05) (Table 
II). Since radioresistant help was normal, the observed de-
pressed help in nonirradiated cultures may be an indirect indi-
cation of depressed radiosensitive help in AD. 
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T- Cell S ubset Enumeration 
We did not detect differ ences in absolute and proportional 
T-cell numbers between controls (82.4 ± 2.3%) and patients 
with AD (81.9 ± 1.2%), p > 0.05. 
We noted a marked decrease, however, in the percentage of 
Ty cells (%Ty/T) in patients with AD, 6.24 ± 2.8 (x ± SEM) 
when compared with normal controls (N), 12.1 ± 2.5, p < 0.01, 
n = 18 pairs (Table II) . The mean Ty level established prior to 
the study in 20 unmatched controls was 13.9 ± 3.9. The mean 
percentages of Tp. cells (%Tp./ T) for 12 pairs of normals and 
patients with AD were 50.3 ± 13.2 (N) and 58.9 ± 11.1 (AD), 
but the slight elevation in atopic Tp. was not statistically sig-
nificant, p > 0.05. 
Removal from atopic serum and overnight culture in the 
presence of FBS did not unmask, induce, or allow reexpression 
of the FclgG receptor in atopic T cells (precultme, 7.6 ± 1.0% 
Ty; postcultme, 6.8 ± 1.1% Ty in AD vs. normals; preculture, 
10.6 ± 0.8; postculture; 12.5 ± 0.7 %Ty, n = 6 pairs). 
We next looked at the possibility t hat Ty reduction could 
resul t from a preferential atopic Ty cell adherence to plastic 
flasks du:ring monocyte removal. Vibration and lidocaine-re-
leased [32] loosely adherent cells rosetted with SEN, purified 
over Ficoll-Hypaque, and enumerated forTy percentages failed 
to demonstrate any differences between normal and atopic 
subj ects for % Ty (normal 14.2 ± 3 vs. AD 13.5 ± 4), n = 5 
pairs. Thus, atopic T y cells were not selectively adherent to the 
flasks. 
Could there be a disproportionate contamination of the nor-
mal and atopic T-cell preparations by monocytes? Monocytes 
bear FclgG receptors, and a significant proportion ofT [33] and 
Ty [34] cells bear a monocyte antigen on their smface as 
detected by monoclonal antibody OKM1. However, when we 
counted percent ANAE-staining monocytes in cytocentrifuge 
T-cell preparations, virtually identical values were obtained-
0.97 ± 0.10% for normal and 0.96 ± 0.18% for atopic T cells, N 
= 5 pairs. 
Percent T cells with MGG azurophilic granules in cytocen-
trifuge preparations were depressed in patients with AD, 6.55 
± 1.9 vs. 9.73 ± 1.7 (normals), in proportions similar to Ty cells, 
but this escaped statistical significance (0.2 > p > 0.05) . Percent 
T cells with ANAE-positive cytoplasmic globules were 83.0 ± 
3.0 (N) and 81.9 ± 2.9 (AD), p > 0.05. The %Ty cells correlated 
with ANAE cells at r = 0.79. 
Raji Cell Assay for lgG Immune Complexes 
If lgG immune complexes were present in atopic sera, these 
could bind FclgG receptors and block the detection of Ty cells 
by EA rosetting. 
TABLE II. PWM stimulated T-cell help for l gG synthesis 
comparison of helper fun ction by nonirradiated T cells" 
Normal B cells" 
N-T 
AD-T 
n = 10 pairs. 
0.1" 
89 ± 5% 
60 ± 13% 
p < 0.05 
" Expressed as % of optimal help. 
"B cells at 1 X 101;/ml. 
,. Concentration ofT cells added X 10';/ ml. 
1.0 '' 
89 ± 4.3% 
73 ± 8.4% 
0.1 > p > 0.05 
TABLE III. Proportions ofT cells with Fe receptors for lgG (T, ) and 
IgM (T,, ) 
Normal controls 
Atopic dermatitis 
"xSEM. 
% T , 
12.10 ± 2.5" 
6.24 ± 2.8 
n = 18 
p < .01 
% T,, 
50.3 ± 13.2 
58.9 ± 11.1 
n = 12 
p > .05 
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IgG immune complexes were determined with sera obtained 
at the time of cell separation. Systemic lupus erythematosus 
(SLE) sera represented the positive controls, with binding of 
49.2 ± 1.27 and 36.3 ± 4.06 X 103 counts/min 125I antihuman 
IgG bound per 2 X 106 Raji cells. Mean counts of patients with 
AD (15.7 ± 1.17 X 10a counts/ min) did not differ from control 
levels (15.7 ± 1.7 X 103 counts/ min), p > 0.05. There was no 
correlation between Ty and IgG immune complexes (r = 0.05). 
Thus, IgG immune complexes in atopic sera could not account 
for the observed decrease in Ty cells. 
Correlation of Serum IgE Levels, Ty, and Clinical Status 
When compared with clinical parameters, depression of Ty 
cells inversely correlated with elevation of log serum IgE levels 
at r = -0.64, p < 0.05, n = 21 (Fig 4). Comparison of Ty with 
clinical extent and severity scores indicated a possible relation-
ship. Of the 12 patients with Ty levels of under 7%, 9 had extent 
+ severity scores greater than 7. In contrast, 3 of the 4 patients 
with greater than 7% Ty had extent+ severity scores less than 
6 (milder disease). 
DISCUSSION 
The prevailing notion has been that T-cell defects in patients 
with AD must be responsible for the hyperimmunoglobulinemia 
E in this disease (1,10,35-38]. Attempts to demonstrate a func-
tional defect in AD T-cell suppression of spontaneous IgE 
production by AD B cells in vitro have not been consistent, and 
some patients, whose MNL overproduce IgE, clearly have nor-
malT-suppressor function [9,10]. Although normal OKT8+ cells 
have been shown to be able to at least partially suppress AD 
MNL spontaneous IgE production [39], there are methodologic 
problems with this assay [ 40]. Spontaneous IgE production 
represents the production of IgE by preactivated, lymphoblas-
toid, terminally differentiated IgE-producing B cells, and a 
log IgE 
3 
2 
0 2 4 
log lg E vs % T r 
r =0.64 
• 
6 8 10 12 
% T r 
14 
FJG 4. Log lgE vs. % Ty. The log serum lgE at the time ofT-cell 
separation correlated with % Ty level at r = -0.64 (correlation coeffi-
cient). 
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majority of the IgE measmed is preformed and released by the 
cells in vitro [ 40]. Ideally, T -cell regulation of these abnormal 
B cells would be studied at the activation and differentiation 
stages of IgE production, and, although some systems are 
promising [9,41], they have yet to be confirmed. 
These methodologic problems emphasize the need to use a 
well-defmed system of T cell-dependent B-cell activation and 
differentiation, such as the PWM-induced immunoglobulin pro-
duction assay [11-15,30] in order to explore the basic aspects of 
T -B cell interactions in AD. This system is advantageous since 
(1) suppression is mediated by Ty cells (13,15] and (2) allogeneic 
combinations of cells do not stimulate or inhibit IgG synthesis 
[11,12,42], thus allowing us to coculture various combinations 
of T and B cells. 
Dming our investigations into normal and AD T -B cell 
interactions, we found that patients with atopic dermatitis 
demonstrated a decrease in B-cell IgG production. Clinically, 
hypoproduction of IgG by AD B cells may not be recognized as 
a decrease in serum IgG since most AD immune defects are 
severe only during flares of the disease and the IgG half-life is 
long (6]. However, occasional reports have described depressed 
serum IgG in AD [ 43] and a reduction of specific immunoglob-
ulin during disease exacerbations could have relevance to the 
frequently accompanying staphylococcal pyodermas [6]. 
Several reasons for decreased AD IgG production in vitro are 
possible. PWM-stimulated IgG synthesis was significantly re-
duced in AD, whether studied in unfractionated MNL or in 
purified autologous T- and B-cell recombinations (Fig 2, Table 
II). This decrease was not due to deficient atopic T cells or 
excessive atopic T-suppressor activity (Table I). PWM-stimu-
lated IgG synthesis by atopic B cells, whether cocultured with 
helper concentrations of normal T cells or atopic T cells, was 
significantly less than IgG synthesis by normal B cells (Fig 3). 
One possibility is a primary B-cell defect in AD. The reduc-
tion in IgG production could be due to a decrease in the number 
of PWM-responsive B cells, or to a decrease in IgG produced 
per B cell. In normals, Stevens et al demonstrated, using 
limiting dilution analysis of PWM-responsive B cells, that the 
rate of IgG production per B cell was constant, and that 
variations between subjects were due to variations in precursor 
cell frequency placed in the cultures [ 45]. However, in SLE, 
evidence has recently been provided that the decrease in PWM-
induced IgM production was probably due to a decrease in rate 
of synthesis per B cell [ 46]. In fact, patients with SLE also have 
increased lymphoblastoid, spontaneously secreting B cells, sim-
ilar to those which produce IgE in atopies [ 4 7]. Similar B-cell 
defects may be involved. 
A second possibility to explain the reduction in AD IgG 
p1·oduction in the presence of abnormal monocyte suppressors 
of IgG synthesis present in the "B-enriched cells." Monocyte 
function is known to be abnormal in AD and may well play a 
role [ 4]. It should be noted that monocyte suppressors of 
spontaneous IgE synthesis (K Cooper, K Kang, J Hanifm, 
unpublished data) and of PHA responsiveness have been looked 
for and not found in patients with AD [5]. Although normal 
monocytes can be suppressive at high concentrations, in these 
preparations, monocytes are depleted relative to unfractionated 
MNL (monocytes/ B cell= 3/ 1 in MNL, 1/ 1 in "B enriched"). 
The question of monocyte suppression canot be ruled out from 
the data presented here and should be the subject of further 
investigation. 
As demonstrated by Stevens et al [25], the PWM-reactive B 
cells responsible for IgG production most probably represent 
"recent memory" B cells following recent antigen stimulation. 
Development of these antigen-specific B cells requires the 
interaction of a radiosensitive (proliferating) OKT4+, Ia+ cell 
and a radioresistant (nonproliferating) OKT4 ... , Ia- cell [21-
25]. 
Thus, a third possibility could be a defect in the generation 
of the radiosensitive helper T cells, since in these assays, AD 
radioresistant helper T-cell activity was not deficient, and non-
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irradiated AD T-cell help was reduced (Table II) . In this 
hypothesis the in vivo generation of antigen-stimulated "recent 
memory" B cells responsive to PWM would be secondarily 
reduced, since both types of helpers are required for this fun c-
tion. Normal levels of the resting OKT.,+ cell do not rule out 
this possibility, since the defect proposed is distal to this point 
in differentiation and may be functional rath er than numerical. 
A defect in functional capacity at t he level of the radiosens i-
tive helper-cell differentiation may explain numerous other 
abnormalities in AD such as decreased antigen and mitogen 
responsiveness [5, 7]. Our findings [ 48] and those of Leung [ 49] 
and Shohat [50] indicate a defect in the in vivo generation of 
mature OKTH+ cytotoxic/suppressor effector cells. S ince this 
maturation is dependent on the proliferating, radiosensitive 
OKT. + helper/inducer, the defect may lie in either the OKT~ + 
precursor or in the OKT. + inducer. Whether Ty cell reduction 
in AD is due to reduced function of the OKT. + inducer or other 
cells which induce FclgG receptors on precursor cells via thymic 
factors and cAMP [51] is unknown. 
The PWM-stirnulated IgG synthesis assay is especially useful 
since T suppression in this system is mediated predominantly 
by Ty cells [13,15). This allows us to assess directly the func-
tional consequence of reduction in the Ty population in AD 
[36,38,52]. As seen in Table I, atopic T cells exerted normal 
suppressor influences on IgG synthesis by B cells in 3 responder 
cell populations (allogeneic MNL, normal B-enriched, and AD 
B-enriched cells). 
Thus in AD, the observed reduction ofTy cells is not reflected 
by reduced suppressor activity in the IgG synt hesis assay. 
Whether the IgE T suppressor resides in the Ty population is 
an open question. 
Investigations of other suppressor cell systems in atopic der-
matitis have yielded mixed results. Con-A-activated suppres-
sors have been reported as normal [53-55] or decreased [38] 
and spontaneous suppressor cell loss has been reported as 
normal [5] or decreased [37]. Sting! et al [38] noted that Con-
A-activated T suppression of IgG synthesis was reduced in AD 
and they interpreted this as due to T r reduction. However, Con-
A-activated suppressors ar e derived from T ,, cells and only 
partially fro m Ty cells [16]. Therefore their finding more likely 
reflects the atopic reduction of OKT s + cells that mediate this 
fu nction [18,48,49). 
If Ty-cell reduction does not result in defective immunoglob-
ulin suppression, what is the functional consequence of their 
depression? Ty cells are heterogeneous, and in addition to their 
abili ty to suppress B-cell differentiation [15], subpopula tions of 
Ty cells suppress the autologous mixed leukocyte reaction 
[56], mediate ADCC and natural killer cells (NK) [57], and 
differentially respond and act as accessory cells for Tp. cells in 
PHA stimulation [58]. Interestingly, patients with AD have 
defects in most of these categories. Defective lymphocyte 
ADCC [3,4], reduced cytotoxic T-lymphocyte function [50], and 
depressed PHA responses [5], each of which could be related to 
these functions, have all been reported in AD. 
In conclusion, identification of defects in numbers of im-
munoregulatory T-cell subsets and in the generation of PWM-
responsive B cells, along with the pharmacologic abnormali ties 
in these cells [59,60], is bringing us closer to appreciating the 
complex interations of these events in atopic dermatitis. 
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Pentadecylcatechol (PDC) (1 mg) incorporated into 
liposomes (PDC-liposomes) and given by intracardiac 
injection to guinea pigs 1 week prior to attempted topical 
sensitization to PDC significantly inhibited that sensiti-
zation as evidenced by patch tests done 2 weeks after the 
attempted topical sensitization. PDC (1 mg) dissolved in 
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ethanol did not significantly inhibit sensitization. Sensi-
tization inhibition was specific since dinitrochloroben-
zene sensitization was not inhibited by prior intracar-
diac treatment with PDC-liposomes. In addition, the sen-
sitization to PDC was no longer inhibited if the time 
between the intracardiac PDC-liposome injection and 
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